![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 26, 2023 1:40:39 PM
Shionogi has 1 but it is not started PHIII trial yet.
Then there is TolloVID. It is OTC. Developed by Dr Dorit Arad/Israel. Product of Todos Medical.
those who had been diagnosed with mild Covid, artery and central cardiovascular function were affected by the disease two to three months after infection.
Usually, you’d expect inflammation to decrease with time after infection, and for all the physiological functions to go back to normal or a healthy level.
Participants for the study, which was part of the University of Split’s NormPreven project, were mostly aged under 50 and healthy
https://www.msn.com/en-gb/news/other/mild-covid-can-lead-to-long-term-impact-on-cardiovascular-health-study-claims/ar-AA1amhhe
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM